Please login to the form below

Not currently logged in
Email:
Password:

nalmefene

This page shows the latest nalmefene news and features for those working in and with pharma, biotech and healthcare.

Acorda acquires Biotie to expand in Parkinson's disease

Acorda acquires Biotie to expand in Parkinson's disease

Biotie also has a royalty stream from Lundbeck's sales of Selincro(nalmefene), which was launched in 2013 for the treatment of alcohol dependency.

Latest news

More from news
Approximately 5 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Pharma deals during September 2012 Pharma deals during September 2012

    from 2006 for Selincro (nalmefene), a novel opioid system modulator to treat alcohol dependence. Linked to this investment, the royalty rates in countries outside Europe and the US have been reduced

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics